Albala D - Search Results

1

The Rationale for Optimal Combination Therapy With Sipuleucel-T for Patients With Castration-resistant Prostate Cancer.

Mouraviev V, Mariados N, Albala D, Concepcion RS, Shore ND, Sims RB, Emberton M, Pieczonka CM. Mouraviev V, et al. Among authors: albala d. Rev Urol. 2014;16(3):122-30. Rev Urol. 2014. PMID: 25337042 Free PMC article. Review.

2

Comparison of fracture risk assessment tool score to bone mineral density for estimating fracture risk in patients with advanced prostate cancer on androgen deprivation therapy.

James H 3rd, Aleksic I, Bienz MN, Pieczonka C, Iannotta P, Albala D, Mariados N, Mouraviev V, Saad F. James H 3rd, et al. Among authors: albala d. Urology. 2014 Jul;84(1):164-8. doi: 10.1016/j.urology.2013.12.071. Urology. 2014. PMID: 24976229

3

Sipuleucel-T for the Treatment of Patients With Metastatic Castrate-resistant Prostate Cancer: Considerations for Clinical Practice.

Pieczonka CM, Telonis D, Mouraviev V, Albala D. Pieczonka CM, et al. Among authors: albala d. Rev Urol. 2015;17(4):203-10. Rev Urol. 2015. PMID: 26839517 Free PMC article.

4

Associated Medical Professionals, Syracuse, NY.

Albala DM, Mariados NF, Pieczonka CM. Albala DM, et al. Rev Urol. 2016;18(1):35-7. Rev Urol. 2016. PMID: 27162511 Free PMC article. No abstract available.

5

Advanced prostate cancer in large group practices.

Albala DM, Kirsh GM, Shore ND. Albala DM, et al. Rev Urol. 2016;18(4):226-230. doi: 10.3909/riu0737. Rev Urol. 2016. PMID: 28127265 Free PMC article. No abstract available.

6

Financial comparative analysis of minimally invasive surgery to open surgery for localized prostate cancer: a single-institution experience.

Mouraviev V, Nosnik I, Sun L, Robertson CN, Walther P, Albala D, Moul JW, Polascik TJ. Mouraviev V, et al. Among authors: albala d. Urology. 2007 Feb;69(2):311-4. doi: 10.1016/j.urology.2006.10.025. Urology. 2007. PMID: 17320670

7

A Head-to-Head Comparative Phase II Study of Standard Urine Culture and Sensitivity Versus DNA Next-generation Sequencing Testing for Urinary Tract Infections.

McDonald M, Kameh D, Johnson ME, Johansen TEB, Albala D, Mouraviev V. McDonald M, et al. Among authors: albala d. Rev Urol. 2017;19(4):213-220. doi: 10.3909/riu0780. Rev Urol. 2017. PMID: 29472825 Free PMC article. Review.

8

Clinical Proof-of-concept of a Novel Platform Utilizing Biopsy-derived Live Single Cells, Phenotypic Biomarkers, and Machine Learning Toward a Precision Risk Stratification Test for Prostate Cancer Grade Groups 1 and 2 (Gleason 3 + 3 and 3 + 4).

Albala D, Manak MS, Varsanik JS, Rashid HH, Mouraviev V, Zappala SM, Ette E, Kella N, Rieger-Christ KM, Sant GR, Chander AC. Albala D, et al. Urology. 2019 Feb;124:198-206. doi: 10.1016/j.urology.2018.09.032. Epub 2018 Oct 10. Urology. 2019. PMID: 30312670

9

Optimizing the role of androgen deprivation therapy in advanced prostate cancer: Challenges beyond the guidelines.

Shore ND, Antonarakis ES, Cookson MS, Crawford ED, Morgans AK, Albala DM, Hafron J, Harris RG, Saltzstein D, Brown GA, Henderson J, Lowentritt B, Spier JM, Concepcion R. Shore ND, et al. Among authors: albala dm. Prostate. 2020 May;80(6):527-544. doi: 10.1002/pros.23967. Epub 2020 Mar 4. Prostate. 2020. PMID: 32130741 Free PMC article. Review.

10

Prostate Cancer Academy 2016: Presentation summaries.

Crawford ED, Albala DM, Wysocki JS, Lepor H, Ross AE, Finkelstein SE, Keane T, Freedland S, Harris R, Shore ND, Ryan CJ. Crawford ED, et al. Among authors: albala dm. Rev Urol. 2016;18(4):205-213. doi: 10.3909/riuPCA2016. Rev Urol. 2016. PMID: 28127262 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

208 results

Search Page

Filters